INTRODUCTION
Ischemic heart disease, commonly called coronary artery disease, is a disease characterized by reduced blood supply to the heart. It has been the top one cause of life loss each year all over the world, bringing about 8.14 million fatalities in 2013 up from 5.74 million fatalities in 1990. It has been a tough global health problem to be solved according to the data analysis of cause-specific mortality for 240 causes of death during 1990 -2013 [1] . Although kinds of drugs such as aspirin, thrombolysis agents, β receptor blockers and ACE inhibitors have been used to treat AMI [2, 3] , AMI is still one of the major cause of ischemic heart diseases, and with high rate of morbidity and mortality [4] . Therefore, the safer and more effective drugs still need to be explored for clinical use.
SGI is also known as Bai Se Tong, and its components are originated from danshen (Salvia miltiorrhiza Bge.) and chuanxiong (Ligusticum chuanxiong Hort.). It has been widely used in cerebral ischemia disease and other ischemic diseases in Asia. Tanshinol and ligustrazine hydrochloride, the active ingredients of SGI, have been confirmed to exhibit powerful protective effects on cardio-cerebrovascular disease in vitro and in vivo, and they have shown various pharmacological activities such as anti-oxidation, anti-apoptosis, and anticoagulation in the treatment of ischemic and infarction disease [5] [6] [7] .
Previous studies have shown that SGI possesses protective effects on cerebral, and its potential mechanisms are involved in antiinflammation, anti-oxidation and anticoagulation [8] . And what's more, clinical applications and animal experimental studies have demonstrated that there are seldom adverse effects after administration of SGI [8, 9] . However, the cardioprotective effect and mechanisms of SGI has been rarely reported.
The main objective of our study is to investigate the cardioprotective effects and potential mechanisms of SGI on AMI injury. .25 mg/kg). PNS has been widely used in cerebral and myocardial ischemia disease in clinics. In this study, it was treated as a positive control. The rats of control and AMI groups were administered with 5 % of glucose injection via caudal vein for 7 days consecutively, while the rest of rats were administered for 7 days respectively with the drugs accordingly.
EXPERIMENTAL
AMI injury model was created according to our previous study with slight modifications [11] . The rats were anesthetized with 25 % of urethanum (1 g/kg, intraperitoneally). Following intubation and artificial ventilation, the surgical operation was performed to expose heart. The heart was rapidly exposed and the left anterior descending coronary artery was ligated with a suture, control group just exposed heart without ligating. Electrocardiography was recorded by ECG2206B system (Nanjing Hengteng electronic technology Co., Ltd., Nanjing, China) before and 5, 15, 30, 60, 120 min after the surgery, the ECG recording speed was 50 mm/s at a voltage of 10 mm/mV. The ST segment elevation of limb lead (II) ECG was used to determine the AMI injury. After the last time ECG recording, blood samples were collected from abdominal aorta to separate out serum by centrifugation at 3000 rpm for 10 min for further biochemical analysis. Successively, the hearts of all rats were got and performed for infraction size, pathology, and qPCR researches.
Measurement of serum biomarker of AMI
The serum content of CK, cTn-I and BNP was measured by corresponding commercial enzyme-linked immunosorbent assay kits described above. Spectrophotometry method was used to detect the kits by multi-detection microplate reader (Synergy™ HT, BioTek, USA). All protocols were performed according to the kit manufacture recommendations.
Histopathological analysis
Left ventricular heart tissues were fixed in paraformaldehyde and embedded in paraffin, and then slice into serial very thin pieces using microtome. The pieces were stained with H&E to observe the change of myocardium s by a microscope (Olympus CX31, Japan).
Determination of infarct size
The infarct size was determined as previously described [11] . The TTC-stained areas (red staining) and TTC-stained negative areas (myocardial infarction) were isolated and the infarct size was expressed as the percentage of the myocardial weight.
Determination of Ca 2+ -Mg

2+
-ATPase and Na + -K + -ATPase activities
Myocardial tissues were weighed and made into homogenates with normal saline. After centrifugation, the supernatant was obtained and used to determinate the protein concentration and the enzyme activity. The procedure used were strictly in accordance with the instruction of ATPase assay kits and Bradford Protein Assay Kit.
Measurement of mRNA expression of CaM and CaMK II
RNA was obtained from the myocardial tissues. Myocardial tissues were grinded with liquid nitrogen. Later, mRNA was extracted by RNA Trizol reagent and RNA integrity was determined by 1 % of agarose gel. cDNAs were reversely transcribed using each RNA sample and were amplified by PCR. The primers sequences for rat CaM were: F:5' GATAAGGATGGCAATGGC TACA3' R:5'CGATGTCTGCTTCCCTGATCAT3', CaMK II were: F:5'GTGATGGGAAGTGGCA GAATA3' R: 5'CGTGGCACTGTTGACAATTAG A3' and β-actin were: F:5'CCTGTGGCA TCCATGAAACTAC3' R: 5'CTTCTGCATCCTG TCAGCAAT3'. β-actin was used as a reference gene. The mRNA relative expression levels of CaM and CaMK II were normalized to β-actin and calculated using the 2 -ΔΔCT method.
Measurement of intracellular calcium concentration
Changes in (Ca 2+ )i concentration were measured by Ca 2+ sensitive fluorescent indicator Fluo-3-AM and LSCM (LSM 510 META, Zeiss, Germany). H9c2 cells were cultivated with or without SGI (0.08, 0.28 and 0.48 μmol/L, calculated by ligustrazine hydrochloride), NAC(1 mmol/L) for 2 h except control group, then added 1 μmol/L DOX cultivated for 48 h. The cells were quickly flushed and incubated with 5 μM Fluo-3-AM in a glass-bottom dish for 30 min at 37 °C and quickly flushed three times with PBS buffer and incubated for 15 min. (Ca 2+ )i was measured as described previously [12] . Fluorescence was excited at a wavelength of 490 nm and emitted light was observed at 525 nm. Zeiss LSM image browser, a data processing system, was used to calculate intracellular fluorescence intensity.
Statistics
All numerical results are presented as mean ± SEM and statistical significance was analyzed with one-way analysis of variance (ANOVA) using SPSS 17.0 software. Differences were considered significant at p < 0.05.
RESULTS
SGI ameliorates ECG and decreases biomarkers of AMI injury in AMI rats
The myocardial injury can lead to abnormal ST segment change, so ECG can reflect the myocardial injury directly. In our present study, AMI injury resulted in significant ST segment elevation in the AMI group, which demonstrated that the AMI injury model of rats was successfully established. In addition, compared with AMI group, the ST segments of other groups were significantly reduced in a dose and timedependent manner ( Figure  1A ). More importantly, the ST segment elevation of PNS and SGI (H) was significantly reduced within 120 min of the experiment (p < 0.01 or 0.05). The ECG of rats at 120 min are shown in Figure 1B . What's more, we also measured the content of CK, cTnI and BNP to examine the extent of myocardial damage and the protective effects of SGI. As shown in Table 1 , the CK, cTnI and BNP contents of AMI group rats were higher than those for control group (p < 0.05). However, after being treated with SGI or PNS, the serum CK, cTnI and BNP contents were significantly decreased (p < 0.01 or 0.05). 
SGI decreases infarct size and protects myocardium structure in AMI rats
As shown in Figure 2B , myocardial infarct size in AMI group was significantly larger than that of control group (p < 0.01). When treated with SGI or PNS, myocardial infarct size was significantly reduced (p < 0.01 or p < 0.05), except SGI (L). TTC staining of myocardium intuitively revealed the degree of AMI injury of rats (Figure 2A, a-f) . Meanwhile, histopathological analysis showed that myocardium structure of control group rats were normal with clear boundaries, but AMI injury in AMI group caused myocardium to be remarkably loose and disordered. Rats treated with PNS or SGI can ameliorate irregular arrangement of myocardium ( Figure 2C , a-f).
SGI regulates Ca 2+ related enzyme activity and mRNA expression
As shown in Table 2 , rats suffered from AMI injury induced to significant decline of the Ca 2+ -Mg 2+ -ATPase and Na + -K + -ATPase activities (p < 0.01). PNS and SGI pretreatment protected their activities decline from AMI injury (p < 0.01 or p < 0.05). Meanwhile, CaM and CaMK II expressions were significantly improved in AMI injury rats (p < 0.01). On the contrary, pretreatment of PNS and SGI significantly decreased CaM and CaMK II mRNA expression in some degree (p < 0.01 or p < 0.05).
SGI decreases DOX-induced H9c2 cells (Ca 2+ )i overload
In order to confirm the effect of SGI on (Ca 2+ )i overload, we investigated it in DOX-induced H9c2 cells injury model. Intuitively, the fluorescence intensity of DOX group was more severe than other groups ( Figure 3A) . Then, 35 cells were randomly selected in each group to calculate the relative intracellular calcium concentration. The results show that (Ca 2+ )i of the DOX group was higher than that of the control group (p < 0.01). Similarly, (Ca 2+ )i of NAC group, all the SGI groups had a significantly decrease compared with DOX group (p < 0.01) ( Figure 3B ). 
DISCUSSION
SGI, consisted of two effective ingredients ligustrazine hydrochloride and tanshinol, has shown multiple effects on cerebral disease, but the cardioprotective effect and mechanisms of SGI has been rarely reported [8] . The objective of our present study is to examine whether SGI plays a protective role in AMI injury and explore its potential mechanisms.
ECG and the content of CK, cTnI and BNP have been widely used as biomarkers of myocardial injury. Consistent with the previous studies [11] , we observed significant increase of CK, cTnI and BNP content and elevation of typical ECG ST segment in rats subjected to acute myocardial infarction. The pretreatment of SGI can decline the high level of CK, cTnI, BNP and the elevation of ECG ST segment. Meanwhile, we also found that the area at risk was significantly reduced and myocardial structure was better-preserved in SGI pretreatment rats. All in all, these results have demonstrated the cardioprotective effects of SGI.
As an important second messenger, Ca 2+ signal is a leading mediator in the management of many physiological and cellular activities, such as muscle contraction, metabolism, cell necrosis, apoptosis and autophagy and so on [13, 14] . In ischemic and infarcted myocardium, the deficiency of ATP triggers the lower activity of 
